These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21433266)

  • 1. Prediction of outcomes after percutaneous coronary intervention for unprotected left main coronary artery stenosis using the EuroSCORE.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):633. PubMed ID: 21433266
    [No Abstract]   [Full Text] [Related]  

  • 2. EuroSCORE is a good global predictor of long-term outcomes in high-risk but not in low-risk patients after unprotected left main angioplasty.
    Rekik S; Brunet J; Bayet G; Hager FX; Meille L; Quatre JM; Sainsous J
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):625-32. PubMed ID: 20578163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unprotected left main intervention: the light at the end of the tunnel?
    Stone GW; Mintz GS
    Circ Cardiovasc Interv; 2009 Jun; 2(3):156-8. PubMed ID: 20031711
    [No Abstract]   [Full Text] [Related]  

  • 5. Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
    Carrié D; Eltchaninoff H; Lefèvre T; Silvestri M; Brunel P; Fajadet J; Moynagh A; Gilard M; Koning R; Dibie A; Darremont O; Lablanche JM; Blanchard D;
    EuroIntervention; 2011 Oct; 7(6):680-8. PubMed ID: 21986326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If you want to stent ... do intravascular ultrasound!
    Hodgson JM
    JACC Cardiovasc Interv; 2010 Aug; 3(8):818-20. PubMed ID: 20723853
    [No Abstract]   [Full Text] [Related]  

  • 8. The continuing diabetic drug-eluting stents saga from very-late stent thrombosis to very-late late loss.
    Mak KH
    JACC Cardiovasc Interv; 2011 Mar; 4(3):324-6. PubMed ID: 21435611
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis.
    Park SJ; Kim YH; Park DW; Lee SW; Kim WJ; Suh J; Yun SC; Lee CW; Hong MK; Lee JH; Park SW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):167-77. PubMed ID: 20031713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
    Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is CT the better angiogram? Coronary interventions and CT imaging.
    Achenbach S; Ludwig J
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):29-31. PubMed ID: 20129527
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Girasis C; Piazza N; Garcia-Garcia HM; Kukreja N; Garg S; Eindhoven J; Cheng JM; Valgimigli M; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2010 Jun; 3(6):584-94. PubMed ID: 20630451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up after nonurgent percutaneous coronary intervention in unprotected left main coronary arteries.
    Beijk MA; Rittersma SZ; Koch KT; Henriques JP; Baan J; Vis MM; Hoekstra F; Tijssen JG; Piek JJ; Kloek JJ; de Mol BA; de Winter RJ
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1026-36. PubMed ID: 20517965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of the Janus carbostent.
    Kornowski R
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):249-50. PubMed ID: 19156897
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left main invention an evolving perspective.
    Ellis SG
    JACC Cardiovasc Interv; 2010 Jun; 3(6):642-7. PubMed ID: 20630457
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender medicine and drug eluting coronary stents.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):814-6. PubMed ID: 21104730
    [No Abstract]   [Full Text] [Related]  

  • 19. High glycemic stenting menu.
    Hillegass WB
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):934-5. PubMed ID: 21108370
    [No Abstract]   [Full Text] [Related]  

  • 20. Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study.
    Salvatella N; Morice MC; Darremont O; Tafflet M; Garot P; Leymarie JL; Chevalier B; Lefèvre T; Louvard Y; Boudou N; Dumonteil N; Carrié D
    EuroIntervention; 2011 Oct; 7(6):689-96. PubMed ID: 21986327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.